LGALS9 and cancer: Additionally, blockage of the TIM-3-Gal-9 pathway causes a significant decrease in the immunosuppressive activity of Tregs in vitro [151], and this blockade has wholly reversed Treg-mediated immune suppression in some types of cancer and significantly decreased the development of cancer [140].